{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:12:05Z","timestamp":1782166325845,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboudumc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.kint.2025.05.010","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:07:03Z","timestamp":1752829623000},"page":"178-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is the Mayo prediction tool for MGRS ready for prime time?"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-6921","authenticated-orcid":false,"given":"Jack F.","family":"Wetzels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.05.010_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.05.010_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.010_bib3","doi-asserted-by":"crossref","first-page":"101040","DOI":"10.1016\/j.blre.2023.101040","article-title":"State-of-the-art review on AL amyloidosis in Western countries: epidemiology, health economics, risk assessment and therapeutic management of a rare disease","volume":"59","author":"Sabinot","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.kint.2025.05.010_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bjh.15987","article-title":"Long term outcomes in monoclonal gammopathy of renal significance","volume":"186","author":"Khera","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2025.05.010_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.kint.2025.04.018","article-title":"The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy","volume":"108","author":"Klomjit","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.010_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2215\/CJN.0000000000000358","article-title":"Monoclonal gammopathy and its association with progression to kidney failure and mortality in patients with CKD","volume":"19","author":"Sy-Go","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.010_bib7","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1681\/ASN.2020010054","article-title":"Rate and predictors of finding monoclonal gammopathy of renal significance (MGRS) lesions on kidney biopsy in patients with monoclonal gammopathy","volume":"31","author":"Klomjit","year":"2020","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382500420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382500420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:22:14Z","timestamp":1752852134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382500420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S008525382500420X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.05.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the Mayo prediction tool for MGRS ready for prime time?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}